Fabry disease in infancy and early childhood: a systematic literature review

Dawn A Laney1, Dawn S Peck2, Andrea M Atherton3

  • 1Division of Medical Genetics, Department of Human Genetics, Decatur, Georgia, USA.

Insights

Fabry disease symptoms, including neuropathic pain and gastrointestinal issues, can appear before age five in children. Early detection and specialist referral are crucial for managing this genetic disorder.

Area of Science:

  • Genetics
  • Pediatrics
  • Lysosomal Storage Disorders

Background:

  • Fabry disease is a progressive, X-linked genetic disorder caused by alpha-galactosidase A deficiency.
  • While symptoms in older children are documented, data for infants and early childhood are limited.

Purpose of the Study:

  • To identify the age of symptom onset for specific manifestations of Fabry disease in early childhood.
  • To delineate the early clinical presentation of Fabry disease in pediatric patients.

Main Methods:

  • Systematic retrospective analysis of PubMed-indexed publications and case reports.
  • Focused on pediatric Fabry disease patients under five years of age.

Main Results:

  • Acroparesthesias/neuropathic pain were the most frequent symptom (9 children, ages 2.0-4.0 years).
  • Gastrointestinal issues were also notable (6 children, ages 1.0-4.1 years).

Conclusions:

  • Symptoms of Fabry disease can manifest in early childhood, prior to age five.
  • Timely referral to specialists experienced in pediatric Fabry disease management is strongly indicated.
Abstract

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
649
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
6.5K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.1K